跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
SUGAMMADEX QILU 100 MG/ML SOLUCION INYECTABLE EFG
Approved
STANDARD
SUGAMMADEX QILU 100 MG/ML SOLUCION INYECTABLE EFG
Qilu Pharma Spain S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 22, 2022
Approval ID
de769bbc128e888d
Company
Qilu Pharma Spain S.L.
Type
Standard
Approval Details
Approval Id
de769bbc128e888d
Drug Cima Aemps Name
SUGAMMADEX QILU 100 MG/ML SOLUCION INYECTABLE EFG
Register Number
88425
Holder Company Name
Qilu Pharma Spain S.L.
Marketing Company Name
Sun Pharma Laboratorios S.L.
Holder Company Detail Path
/organization/qilu-pharma-spain-sl
Authorization Date
2022-12-22
Dosage Form
SOLUCIÓN INYECTABLE
Dose
100 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Qilu Pharma Spain S.L.
Company Detail Path
/organization/qilu-pharma-spain-sl
Company Information
Pharmaceutical Company Name
QILU PHARMA SPAIN SL.
Country Name
Spain
City Name
madrid,madrid,country_es
Address
PASEO CASTELLANA, 40 - PISO 8
Active Ingredients
SUGAMMADEX SODIO
108,8 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 22, 2022
Approval ID
de769bbc128e888d
Type
Standard
Back to CIMA-AEMPS Approvals
SUGAMMADEX QILU 100 MG/ML SOLUCION INYECTABLE EFG - CIMA-AEMPS Drug Approval Details
